PURPOSE: Elevated intraocular pressure (IOP) is an important risk factor for glaucoma. Animal models often involve techniques for IOP elevation that are surgically invasive. Here the authors describe a novel and relatively simple method for inducing a highly consistent, modest, and repeatable elevation in IOP for rats and mice. METHODS: IOP was elevated unilaterally by injection of polystyrene microbeads into the anterior chamber to occlude aqueous outflow in rats (2.5-7 microL) and mice (1 microL). The fellow eye received an equivalent saline injection as internal control. The authors used tonometry to measure microbead-induced IOP elevations. Optic nerves were processed histologically to determine axon loss. RESULTS: For rats, a single injection of microbeads raised IOP by 21% to 34%, depending on volume, for approximately 2 weeks, though they were not tracked to full recovery. IOP in the saline-injected eye was constant. An additional injection (5 microL) extended the elevation to 8 weeks. Cumulative pressure exposure for both injections increased linearly. For mice, a single 1-microL injection of microbeads elicited a highly regular 30% elevation in IOP that persisted for more than 3 weeks, with a linear rise in cumulative pressure exposure. For both rats and mice, interanimal variability on a given day was modest, approximately 5% of the mean IOP measurement. Extended elevations (4-5 weeks) induced approximately a 20% loss of axons in both rats and mice. CONCLUSIONS: These data support a novel and flexible model of modest ocular hypertension with axon loss. The maximal duration of IOP elevation will be further characterized in future studies.
PURPOSE: Elevated intraocular pressure (IOP) is an important risk factor for glaucoma. Animal models often involve techniques for IOP elevation that are surgically invasive. Here the authors describe a novel and relatively simple method for inducing a highly consistent, modest, and repeatable elevation in IOP for rats and mice. METHODS: IOP was elevated unilaterally by injection of polystyrene microbeads into the anterior chamber to occlude aqueous outflow in rats (2.5-7 microL) and mice (1 microL). The fellow eye received an equivalent saline injection as internal control. The authors used tonometry to measure microbead-induced IOP elevations. Optic nerves were processed histologically to determine axon loss. RESULTS: For rats, a single injection of microbeads raised IOP by 21% to 34%, depending on volume, for approximately 2 weeks, though they were not tracked to full recovery. IOP in the saline-injected eye was constant. An additional injection (5 microL) extended the elevation to 8 weeks. Cumulative pressure exposure for both injections increased linearly. For mice, a single 1-microL injection of microbeads elicited a highly regular 30% elevation in IOP that persisted for more than 3 weeks, with a linear rise in cumulative pressure exposure. For both rats and mice, interanimal variability on a given day was modest, approximately 5% of the mean IOP measurement. Extended elevations (4-5 weeks) induced approximately a 20% loss of axons in both rats and mice. CONCLUSIONS: These data support a novel and flexible model of modest ocular hypertension with axon loss. The maximal duration of IOP elevation will be further characterized in future studies.
Authors: Hana Levkovitch-Verbin; Harry A Quigley; Keith R G Martin; Danielle Valenta; Lisa A Baumrind; Mary Ellen Pease Journal: Invest Ophthalmol Vis Sci Date: 2002-02 Impact factor: 4.799
Authors: T W Mittag; J Danias; G Pohorenec; H M Yuan; E Burakgazi; R Chalmers-Redman; S M Podos; W G Tatton Journal: Invest Ophthalmol Vis Sci Date: 2000-10 Impact factor: 4.799
Authors: Stuart J McKinnon; Donna M Lehman; Lisa A Kerrigan-Baumrind; Carol A Merges; Mary Ellen Pease; Danielle F Kerrigan; Nancy L Ransom; N Grace Tahzib; Herbert A Reitsamer; Hana Levkovitch-Verbin; Harry A Quigley; Donald J Zack Journal: Invest Ophthalmol Vis Sci Date: 2002-04 Impact factor: 4.799
Authors: Carl Weitlauf; Nicholas J Ward; Wendi S Lambert; Tatiana N Sidorova; Karen W Ho; Rebecca M Sappington; David J Calkins Journal: J Neurosci Date: 2014-11-12 Impact factor: 6.167
Authors: Mary E Pease; Frances E Cone; Scott Gelman; Janice L Son; Harry A Quigley Journal: Invest Ophthalmol Vis Sci Date: 2011-02-22 Impact factor: 4.799
Authors: Hui Chen; Yan Zhao; Mingna Liu; Liang Feng; Zhen Puyang; Ji Yi; Peiji Liang; Hao F Zhang; Jianhua Cang; John B Troy; Xiaorong Liu Journal: Invest Ophthalmol Vis Sci Date: 2015-02-26 Impact factor: 4.799
Authors: Liang Feng; Yan Zhao; Miho Yoshida; Hui Chen; Jessica F Yang; Ted S Kim; Jianhua Cang; John B Troy; Xiaorong Liu Journal: Invest Ophthalmol Vis Sci Date: 2013-02-07 Impact factor: 4.799
Authors: Benjamin J Frankfort; A Kareem Khan; Dennis Y Tse; Inyoung Chung; Ji-Jie Pang; Zhuo Yang; Ronald L Gross; Samuel M Wu Journal: Invest Ophthalmol Vis Sci Date: 2013-01-28 Impact factor: 4.799